Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-04

FDA Approved: EFAVIRENZ — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA granted approval of a supplemental application for efavirenz from Aurobindo Pharma Limited, authorizing its continued generic use and potential indications/…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EFAVIRENZ (efavirenz)

Snippet

SUPPL AP for EFAVIRENZ (EFAVIRENZ)